Biomedical Research Education & Training
Faculty Member

Brandt, Stephen J., M.D.
Professor of Medicine
Professor of Cell and Developmental Biology
Professor of Cancer Biology

Lab Url: N/A

Phone Number: 615-936-1809

Email Address: stephen.brandt@vanderbilt.edu

Brandt, Stephen's picture
Academic history
BS, summa cum laude, Duke University, Durham, N.C.
MD, magna cum laude, Emory Univ School of Med, Atlanta, GA
, Resident, Univ of Virginia Hlth Sciences Ctr, Charlottesville, VA
, Fellow, Hematology-Oncolology., Duke Univ Med Ctr, Durham, N.C.
, Guest Researcher, NHLBI, National Institutes of Health, Bethesda, MD

Office Address   Mailing Address

540B (office) and 540-542 (lab) PRB

777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN 37232-6307 37232-6307


Research Keywords
Transcriptional regulation; basic helix-loop-helix transcription factors; LIM domain proteins; protein dimerization; cell differentiation; hematopoiesis; T-cell leukemia

Patient Care Specialty
Stem Cell Transplant; Hematology

Research Description
Our research focuses on the control of blood cell production and how this is subverted in hematologic malignancy. We have been particularly interested in the oncogene TAL1 (or SCL) that encodes a member of the helix-loop-helix family of transcription factors. Abnormal expression of this gene, originally identified through its involvement by a recurrent chromosomal translocation, constitutes the most frequent gain-of-function mutation in T-cell acute lymphoblastic leukemia (T-ALL). Many helix-loop-helix proteins are important in specification of cell fate, and studies from our lab and others indicate that TAL1 regulates fundamental aspects of hematopoietic differentiation.

We have characterized in detail the expression of TAL1 protein in murine and avian embryogenesis and, most recently, in physiological and pathological vasculogenesis. A series of studies on TAL1 function in erythroid cells have shown this transcription factor undergoes both phosphorylation and acetylation, and we have investigated its interaction with a number of transcriptional coregulators. Work is ongoing to investigate the mechanism by which misexpression of this critical regulator of normal hematopoiesis contributes to leukemic transformation and to identify both its interaction partners and downstream targets. Contemporary techniques of molecular biology and protein biochemistry and both in vitro and in vivo models are used in this research.

Clinical Interests
Leukemias; Lymphomas; Multiple Myeloma

Publications
Dey, S, Curtis, DJ, Jane, SM, Brandt, SJ. The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors. Mol Cell Biol, 30(9), 2181-92, 2010

Wang Y, Klumpp S, Amin HM, Liang H, Li J, Estrov Z, Zweidler-McKay P, Brandt SJ, Agulnick A, and Nagarajan L. SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability. Oncogene, 29, 3044-3053, 2010

Brandt SJ and Koury MJ. Regulation of LMO2 mRNA and protein expression in erythroid differentiation. Haematologica, 94, 447-448, 2009

Cai, Y, Xu, Z, Xie, J, Ham, AJ, Koury, MJ, Hiebert, SW, Brandt, SJ. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors. Biochem Biophys Res Commun, 390(2), 295-301, 2009

Hamid, R, Brandt, SJ. Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells. Mol Oncol, 3(5-6), 451-63, 2009

Brandt, SJ. GATA-1: one TEF customer. Blood, 112(13), 4786-7, 2008

Cai, Y, Xu, Z, Nagarajan, L, Brandt, SJ. Single-stranded DNA-binding proteins regulate the abundance and function of the LIM-homeodomain transcription factor LHX2 in pituitary cells. Biochem Biophys Res Commun, 373(2), 303-8, 2008 PMCID:2496924

Hamid, R, Patterson, J, Brandt, SJ. Genomic structure, alternative splicing and expression of TG-interacting factor, in human myeloid leukemia blasts and cell lines. Biochim Biophys Acta, 1779(5), 347-55, 2008 PMCID:2367313

Odenike OM, Alkan S, Dorie S, Godwin JE, Huo D, Brandt SJ, Green M, Xie J, Zhang Y, Vesole DH, Stiff P, Wright J, Larson RA, Stock W, the University of Chicago Phase II Consortium. The histone deacetylase inhibitor depsipeptide has differential activity in Core Binding Factor acute myeloid leukemia. Clin. Cancer Res., 14, 7095-7101, 2008

Xie, J, Crooke, PS, McKinney, BA, Soltman, J, Brandt, SJ. A computational model of quantitative chromatin immunoprecipitation (ChIP) analysis. Cancer Inform, 6, 138-46, 2008 PMCID:2367313

Engelhardt, BG, Holland, DW, Brandt, SJ, Chinratanalab, W, Goodman, SA, Greer, JP, Jagasia, MH, Kassim, AA, Morgan, DS, Ruffner, KL, Schuening, FG, Wolff, S, Bitting, R, Sulur, P, Stein, RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk Lymphoma, 48(9), 1728-35, 2007 PMCID:2367313

Xu, Z, Meng, X, Cai, Y, Liang, H, Nagarajan, L, Brandt, SJ. Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins. Genes Dev, 21(8), 942-55, 2007 PMCID:1847712

Yang, G, Thompson, MA, Brandt, SJ, Hiebert, SW. Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Oncogene, 26(1), 91-101, 2007

Pimanda, JE, Silberstein, L, Dominici, M, Dekel, B, Bowen, M, Oldham, S, Kallianpur, A, Brandt, SJ, Tannahill, D, G??ttgens, B, Green, AR. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells. Mol Cell Biol, 26(7), 2615-25, 2006 PMCID:1430329

Reed-Inderbitzin, E, Moreno-Miralles, I, Vanden-Eynden, SK, Xie, J, Lutterbach, B, Durst-Goodwin, KL, Luce, KS, Irvin, BJ, Cleary, ML, Brandt, SJ, Hiebert, SW. RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription. Oncogene, 25, 5777-5786, 2006

Tang, T, Shi, Y, Opalenik, SR, Brantley-Sieders, DM, Chen, J, Davidson, JM, Brandt, SJ. Expression of the TAL1/SCL transcription factor in physiological and pathological vascular processes. J Pathol, 210(1), 121-9, 2006 PMCID:1847712

Tran YH, Xu Z, Kato A, Mistry AC, Goya Y, Taira M, Brandt SJ, and Hirose S. Spliced isoforms of LIM-domain-binding protein (CLIM/NLI/Ldb) lacking LIM-interaction domain. J. Biochem., 140, 105-119, 2006

Xu, Z, Meng, X, Cai, Y, Koury, MJ, Brandt, SJ. Recruitment of the SWI/SNF protein Brg1 by a multiprotein complex effects transcriptional repression in murine erythroid progenitors. Biochem J, 399(2), 297-304, 2006 PMCID:1609906

Linggi, BE, Brandt, SJ, Sun, ZW, Hiebert, SW. Translating the histone code into leukemia. J Cell Biochem, 96(5), 938-50, 2005

Thompson, MA, Stumph, J, Henrickson, SE, Rosenwald, A, Wang, Q, Olson, S, Brandt, SJ, Roberts, J, Zhang, X, Shyr, Y, Kinney, MC. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol, 36(5), 494-504, 2005

Wen, J, Huang, S, Pack, SD, Yu Y, Brandt, SJ, Noguchi, CT. Tal1/SCL binding to pericentromeric DNA represses transcription. J Biol Chem, 280(13), 12956-66, 2005

Xu, Z, Huang, S, Chang, LS, Agulnick, AD, Brandt, SJ. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol, 23(21), 7585-99, 2003 PMCID:207591

Koury, MJ, Sawyer, ST, Brandt, SJ. New insights into erythropoiesis. Curr Opin Hematol, 9(2), 93-100, 2002

Tang, T, Arbiser, JL, Brandt, SJ. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells. J Biol Chem, 277(21), 18365-72, 2002

Brandt SJ: Role of the TAL1/SCL Transcription Factor In Normal and Leukemic Hematopoiesis, in Transcription Factors: Normal and Malignant Development of Blood Cells, Ravid K and Licht J (eds.), J Wiley & Sons, 2000

Huang, S, Brandt, SJ. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol, 20(6), 2248-59, 2000 PMCID:110841

Huang, S, Qiu, Y, Shi, Y, Xu, Z, Brandt, SJ. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J, 19(24), 6792-803, 2000 PMCID:305888

Ikpeazu, C, Davidson, MK, Halteman, D, Browning, PJ, Brandt, SJ. Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant, 6(3A), 301-8, 2000

Hasty, AH, Linton, MF, Brandt, SJ, Babaev, VR, Gleaves, LA, Fazio, S. Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation, 99(19), 2571-6, 1999

Huang, S, Qiu, Y, Stein, RW, Brandt, SJ. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene, 18(35), 4958-67, 1999

Tang, T, Prasad, KS, Koury, MJ, Brandt, SJ. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts. Biochem J, 343 Pt 3, 615-20, 1999 PMCID:1220593

Barbosa, MD, Barrat, FJ, Tchernev, VT, Nguyen, QA, Mishra, VS, Colman, SD, Pastural, E, Dufourcq-Lagelouse, R, Fischer, A, Holcombe, RF, Wallace, MR, Brandt, SJ, de Saint Basile, G, Kingsmore, SF. Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse. Hum Mol Genet, 6(7), 1091-8, 1997

Drake, CJ, Brandt, SJ, Trusk, TC, Little, CD. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev Biol, 192(1), 17-30, 1997

Prasad, KS, Brandt, SJ. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein. J Biol Chem, 272(17), 11457-62, 1997

Barbosa, MD, Nguyen, QA, Tchernev, VT, Ashley, JA, Detter, JC, Blaydes, SM, Brandt, SJ, Chotai, D, Hodgman, C, Solari, RC, Lovett, M, Kingsmore, SF. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature, 382(6588), 262-5, 1996

Prasad, KS, Jordan, JE, Koury, MJ, Bondurant, MC, Brandt, SJ. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products. J Biol Chem, 270(19), 11603-11, 1995

Kallianpur, AR, Jordan, JE, Brandt, SJ. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood, 83(5), 1200-8, 1994

Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, and Blaese RM. Fibrosarcoma cells transduced with the IL-6 gene exhibit reduced tumorigenicity, increased immunogenicity and decreased metastatic potential. Cancer Research, 52, 6020-6024, 1992

Sorrentino, BP, Brandt, SJ, Bodine, D, Gottesman, M, Pastan, I, Cline, A, Nienhuis, AW. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science, 257(5066), 99-103, 1992

Bodine, DM, McDonagh, KT, Brandt, SJ, Ney, PA, Agricola, B, Byrne, E, Nienhuis, AW. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci U S A, 87(10), 3738-42, 1990 PMCID:53978

Brandt, SJ, Bodine, DM, Dunbar, CE, Nienhuis, AW. Retroviral-mediated transfer of interleukin-6 into hematopoietic cells of mice results in a syndrome resembling Castleman''s disease. Curr Top Microbiol Immunol, 166, 37-41, 1990

Brandt, SJ, Bodine, DM, Dunbar, CE, Nienhuis, AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman''s disease in mice. J Clin Invest, 86(2), 592-9, 1990 PMCID:296765

Ramakrishnan, S, Xu, FJ, Brandt, SJ, Niedel, JE, Bast, RC, Brown, EL. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest, 83(3), 921-6, 1989 PMCID:303767

Brandt, SJ, Peters, WP, Atwater, SK, Kurtzberg, J, Borowitz, MJ, Jones, RB, Shpall, EJ, Bast, RC, Gilbert, CJ, Oette, DH. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med, 318(14), 869-76, 1988

Le, PT, Kurtzberg, J, Brandt, SJ, Niedel, JE, Haynes, BF, Singer, KH. Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors. J Immunol, 141(4), 1211-7, 1988

Brandt, SJ, Niedel, JE, Bell, RM, Young, WS. Distinct patterns of expression of different protein kinase C mRNAs in rat tissues. Cell, 49(1), 57-63, 1987

Brandt, SJ, Dougherty, RW, Lapetina, EG, Niedel, JE. Pertussis toxin inhibits chemotactic peptide-stimulated generation of inositol phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells. Proc Natl Acad Sci U S A, 82(10), 3277-80, 1985 PMCID:397758

Pember, SO, Barnes, KC, Brandt, SJ, Kinkade, JM. Density heterogeneity of neutrophilic polymorphonuclear leukocytes: gradient fractionation and relationship to chemotactic stimulation. Blood, 61(6), 1105-15, 1983

Brandt, SJ, Barnes, KC, Glass, DB, Kinkade, JM. Glucocorticoid-stimulated increase in chemotactic peptide receptors on differentiating human myeloid leukemia (HL-60) cells. Cancer Res, 41(12 Pt 1), 4947-51, 1981


Postdoctoral Position Available
No

Postdoctoral Position Details
N/A

Updated Date
03/22/2013